🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Watch List: Healthcare Stocks For 2013

Published 01/02/2013, 09:55 AM
Updated 07/09/2023, 06:31 AM
SASY
-
TTEF
-
TTM
-
HLF
-

Best Healthcare stocks with buy ratings originally published at long-term-investments.blogspot.com. This month I hope to discover the best recommended stocks from all sectors in the capital market. I like to start with the healthcare sector, one of the largest ones. Here are some facts for our statistical lovers:

The healthcare sector has 540 companies with a health-related business model. The total market capitalization of all stocks is 64.5 trillion. Stocks from the healthcare sector have an average P/E ratio of 20.78 and they pay in average a dividend yield of 3.37%. The best dividend paying industries are major drug manufactures and Biotechnology companies. Biotech’s are now the second best yielding category with an average industry yield of 2.13%.

Below is a small list with some fundamentals about the most recommended, higher-capitalized stocks from the healthcare sector. I excluded stocks with a market capitalization below USD 2 billion because I think the risk should be much higher than for mid-capitalized stocks.

These are the results: Nine of the 20 best-rated stocks pay dividends. Half of the results are large caps and all stocks have positive expected mid-term earnings per share growth. Yes, healthcare is still a growth opportunity.

Herbalife (HLF) has a market capitalization of $3.56 billion. The company employs 5,100 people, generates revenue of $3.454 billion and has a net income of $412.58 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $634.12 million. The EBITDA margin is 18.36% (the operating margin is 16.28% and the net profit margin 11.94%).

Financial Analysis: The total debt represents 14.08% of the company’s assets and the total debt in relation to the equity amounts to 36.35%. Due to the financial situation, a return on equity of 78.78% was realized. Twelve trailing months earnings per share reached a value of $3.88. Last fiscal year, the company paid $0.73 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 8.48, the P/S ratio is 1.03 and the P/B ratio is finally 6.81. The dividend yield amounts to 3.64% and the beta ratio has a value of 1.68.
Long-Term Stock History
Long-Term Dividends

Long-Term Dividend Yield History
Sanofi SA (SNY) has a market capitalization of $125.26 billion. The company employs 113,719 people, generates revenue of $46.255 billion and has a net income of $6.417 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $13.501 billion. The EBITDA margin is 29.19% (the operating margin is 16.18% and the net profit margin 13.87%).

Financial Analysis: The total debt represents 15.41% of the company’s assets and the total debt in relation to the equity amounts to 27.46%. Due to the financial situation, a return on equity of 10.42% was realized. Twelve trailing months earnings per share reached a value of $2.99. Last fiscal year, the company paid $1.75 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 15.85, the P/S ratio is 2.70 and the P/B ratio is finally 1.69. The dividend yield amounts to 3.57% and the beta ratio has a value of 0.94.
Long-Term Stock History

Long-Term Dividends History
Long-Term Dividend Yield History
Covidien (COV) has a market capitalization of $27.33 billion. The company employs 43,400 people, generates revenue of $11.852 billion and has a net income of $1.902 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $3.044 billion. The EBITDA margin is 25.68% (the operating margin is 20.34% and the net profit margin 16.05%).

Financial Analysis: The total debt represents 22.64% of the company’s assets and the total debt in relation to the equity amounts to 47.70%. Due to the financial situation, a return on equity of 18.66% was realized. Twelve trailing months earnings per share reached a value of $3.92. Last fiscal year, the company paid $0.94 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 14.74, the P/S ratio is 2.31 and the P/B ratio is finally 2.58. The dividend yield amounts to 1.80% and the beta ratio has a value of 0.85.
Long-Term Stock History
Long-Term Dividends History
Long-Term Dividend Yield History
Take a closer look at the full list of the 20 most recommended healthcare stocks. The average P/E ratio amounts to 24.61 and forward P/E ratio is 13.46. The dividend yield has a value of 0.71%. Price to book ratio is 7.74 and price to sales ratio 5.35. The operating margin amounts to 17.35% and the beta ratio is 1.02. Stocks from the list have an average debt to equity ratio of 0.64.

Here is the full table with some fundamentals (TTM)
Healthcare Stocks With Buy Rating
Related Stock Ticker Symbols:
HLF, SNY, COV, UNH, NVO, TMO, RDY, UHS, COO, WPI, SIRO, GILD, HCA, HOLX, JAZZ,
MDVN, ALXN, ARIA, BMRN, CELG

Disclosure: I am long HLF. I receive no compensation to write about these specific stocks, sector or theme. I don't plan to increase or decrease positions or obligations within the next 72 hours.

For the other stocks: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.